Infection and Rashes Flashcards
Define Macule
flat lesion ,usually a circumscribed change of colour
Define Papule
small , solid, elevated lesion
Define Nodule
a large , solid , palpable and elevated lesion
Define Plaque
Plaque – a lesion slightly raised over a larger area
Define Blister
Blister – an elevated lesion ,fluid filled
lesions
Define Ulcer
Ulcer – depressed lesion with loss of surface epithelium
Define Atrophy
Atrophy – a depressed lesion with intact surface epithelium
Define Crust
Crust – a mixture of scale and serum – yellowish accretions on the surface of a lesion
Define Petechiae
Petechiae – non raised red-brown non blanchable
Chicken pox virus
Varicella Zosta Virus
Stages of chicken pox
Virus enters upper respiratory tract
Day 4-6: Viraemia
Incubation period 10-14 days can be longer
First symptom pyrexia for up to 4 days
Headache, malaise, abdo pain
Crops of vesicles over 3-5 days on head neck and trunk (sparse on limbs)
Papule to Vesicle to Pustule to Crust
Management of chicken pox
analgesia – paracetamol for discomfort and pyrexia.
pruritis – antihistamine or calamine lotion
acyclovir only for those at risk of complications or immunocompromised.
Impetigo
Very common superficial, contagious, blistering bacterial infection
Types of impetigo
Non Bullous: Group A beta haemolytic strep pyogenes
Bullous: Fluid lesions (Staph. Aureus)
Presentation of non bullous impetigo
More common 70%
Usually aymptomatic. Occasionally pruritic
Tiny pustules or vesicles that evolve to honey coloured crusted plaques <2cm.
On face. Can be at extremeties where bites , abrasions, lacerations, burns, scratches or trauma could have occurred. Regional lymph nodes enlarged
Little or no surrounding erythema
Presentation of bullous impetigo
Occasionally pruritic. Can be painful
Usually on the face, trunk, extremities, buttocks, or perineal regions.
More common in neonates
Thin roofs and tend to rupture spontaneously
Diagnosis of impetigo
Clinical diagnosis if severe take swabs if:
?MRSA
It is severe or extensive
Recurrent or treatment is failing
Management of impetigo
Neonates: Abx, Erythromycin PO or Vancomycin IV (MRSA +)
Treatment superficial/limited: mupirocin, fusidic acid
Widespread cut. lesions: Oral Abx such as dicloxacillin or flucloxacillin, erythromycin
Deep tissue/systemic infection: Parenteral antibiotic therapy with nafcillin, oxacillin, or clindamycin
Erythema Multiforme
Hypersensitivity reaction resulting in papules forming over back of hands and feet spreading to trunk. Often involving the face. Papules then evolve to plaques and then typical target shaped lesions
Lesions have dusky red centre pale around it and then dusky red ring
Commonly associated with stevens johnson syndrome
Common infections associated with Erythema Multiforme
Herpes Simplex Virus
Mycoplasma Pneumoniae
Can also be:
Hep B, Epstein Barr virus, Cytomegalovirus and more (see BMJ)
Drugs associated with erythema multiforme
most commonly associated-Allopurinol
Recent drugs- Nevirapine, lamotrigine, sertraline, pantoprazole, tramadol
Antibiotics- Sulphonamides, including co-trimoxazole, penicillin cephalosporins, fluoroquinolones, vancomycin
NSAIDs- Piroxicam, fenbufen, ibuprofen, ketoprofen, naproxen, tenoxicam, diclofenac, sulindac
Anti-TB- Rifampicin, ethambutol, isoniazid, pyrazinamide
Anticonvulsants- Barbiturates, carbamazepine, phenytoin, valproate, lamotrigine
Classification of erythema multiforme
EM Minor: Typical targets or raised oedematous papules, with acral distribution, without involvement of mucosal sites and involving <10% total body surface area.
EM Major: Typical targets or raised oedematous papules, with acral distribution, with involvement of mucosal sites and involving <10% total body surface area.
Management of erythema multiforme
Supportive care to maintain hydration and prevent erosions from developing secondary bacterial infection
Treatment of suspected precipitating infections
Suppression therapy with antivirals if recurrent disease is caused by herpes simplex virus (HSV)
Topical or systemic corticosteroids to reduce inflammation.
Stevens Johnson Syndrome (SJS) and Toxic epidermal necrotitis (TEN)
More severe forms of eryrhema multiforme
SJS: <10% total body surface area (TBSA) involvement. Causes include Mycoplasma pneumoniae , viral infections, and vaccines, or drug-related.
TEN: >30% TBSA involvement. Drug-related
Clinical impression of stevens johnson syndrome and toxic epidermal necrotitis
Blisters or macules and flat atypical target lesions
diffuse erythema
Nikolsky’s sign (epidermal layer easily sloughs off when pressure is applied to the affected area)
Mucosal involvement presents with erosions or ulceration of the eyes, lips, mouth, pharynx, oesophagus, GI tract, kidneys, liver, anus, genital area, or urethra
One of the potential complications of SJS/TEN is mucosal involvement of the upper and lower respiratory tract, with vesicle formation, ulceration, and actual mucosal sloughing that may lead to laryngeal stridor, along with possible retractions and oedema of the nasopharynx
Wallace Rule of 9
Splits body into 9 parts allows assessment of the total body surface area an infection may cover:
Head and neck total for front and back: 9%
Each upper limb total for front and back: 9%
Thorax and abdomen front: 18%
Thorax and abdomen back: 18%
Perineum: 1%
Each lower limb total for front and back: 18%.
Management of SJS/TEN
ABG and Oxygen sats to assess for respiratoy distress Dressings with topical Abx Fluid management Analgaesia (avoid NSAIDs where possible) Opthalmic consultation